Northwell Health

Ascertain is a collaborative venture between Northwell Health and Aegis Ventures, aimed at transforming healthcare through innovative company creation. This organization focuses on systematically developing, launching, and commercializing healthcare AI companies, utilizing a comprehensive platform that integrates medical, technological, data, and business resources. By addressing critical issues related to quality, equity, and cost in healthcare, Ascertain seeks to improve patient care and experience. The organization is dedicated to placing patient needs at the forefront of its business models and technology solutions, ultimately striving to enhance long-term health outcomes and advance the overall quality of care.

Avandra is a medical image organization, and the development of a data ecosystem for research and innovation are the goals of Avandra's network.

Truveta is a healthcare data platform that collaborates with physicians, life science researchers, and healthcare organizations to aggregate and analyze medical records information. By compiling data from multiple healthcare systems, Truveta de-identifies and organizes this information to provide valuable medical insights. The platform initially focused on COVID-19, aiming to expedite research efforts, enhance clinician expertise, and support families in making informed healthcare decisions. Through its innovative approach, Truveta connects treatments with outcomes and various health factors, contributing to advancements in medical research and patient care.

Prolucent Health specializes in technology and services aimed at optimizing healthcare workforce management. The company offers a platform that leverages artificial intelligence and advanced analytics to address labor needs through data-driven decision-making. By modernizing recruitment and improving the utilization and cost of healthcare labor, Prolucent enables employers to effectively manage both full-time and contingent workforce components. Additionally, the platform engages healthcare workers, helping them discover suitable job opportunities.

Clarapath, Inc. is a medical robotics company that specializes in automating laboratory processes for digital pathology applications. Founded in 2011 and headquartered in New York, the company has developed Section Star, an automated device that streamlines microtomy through a tape transfer method. Clarapath provides a range of services, including routine histology, pathology consultation, whole slide imaging, quantitative image analysis, and long-term data management. Its anatomic pathology laboratory caters to both human and animal digital pathology needs, serving academic researchers and clinical laboratories. The company aims to enhance the quality and efficiency of lab medicine while reducing costs and labor-related delays. By integrating its technologies, Clarapath facilitates real-time access to tissue samples, thereby standardizing and simplifying the histology process and improving safety and throughput in laboratory settings.

Hume AI is a leading provider of emotional intelligence solutions, founded on the mission of bridging the gap between human emotions and artificial intelligence. They've developed a wide array of products including expression measurement models, text-to-speech models and speech-language models that leverage cutting-edge research in psychology and machine learning. Hume AI’s technology analyzes facial expressions, voice inflections, text, and other data sources to unlock deeper insights into how people feel and engage with the world. By prioritizing scientific rigor and ethical AI practices, Hume AI works across diverse industries—from healthcare to entertainment—to enable more authentic, empathetic, and impactful interactions between humans and technology. Hume AI was founded in 2021 and is based in New York and San Jose.

Optain is a manufacturer of medical equipment and software focused on enhancing healthcare accessibility. The company develops retinal imaging technology that enables noninvasive diagnosis of eye and systemic health conditions in real-time. By leveraging advanced artificial intelligence and automation, Optain's solutions utilize the eye as a critical indicator for early detection and prevention of diseases. This approach facilitates timely and accurate identification of various eye conditions, thereby supporting healthcare professionals in their clinical decision-making processes. Optain aims to create affordable clinical assistance solutions that simplify illness screening, making it possible for individuals to engage in proactive health management anytime and anywhere.

Memora Health Inc., founded in 2016 and based in San Francisco, California, develops an enterprise healthcare productivity platform aimed at automating outpatient communication and enhancing care delivery. The company partners with health systems, health plans, and digital health organizations to streamline clinical workflows, allowing clinicians to focus on their primary responsibilities while proactively engaging patients throughout their care journeys. Memora's platform digitizes high-touch processes, intelligently triaging patient-reported data to the relevant care team members and facilitating proactive, two-way communication between patients and providers. By transforming the way care is delivered, Memora Health seeks to make healthcare more actionable, accessible, and continuous.

Neuvotion is a medical device company focused on creating neurostimulation products aimed at the rehabilitation and physical therapy sectors. The company develops healthcare technology that seeks to restore movement and independence for individuals with movement impairments, such as those resulting from strokes or injuries. By integrating targeted neurostimulation with artificial intelligence, Neuvotion's products provide therapeutic benefits that empower users to manage their own therapy. Additionally, these technologies enable clinicians to utilize advanced tools for monitoring patient progress, either in-person or remotely, enhancing the overall effectiveness of rehabilitation efforts.

Hume AI is a leading provider of emotional intelligence solutions, founded on the mission of bridging the gap between human emotions and artificial intelligence. They've developed a wide array of products including expression measurement models, text-to-speech models and speech-language models that leverage cutting-edge research in psychology and machine learning. Hume AI’s technology analyzes facial expressions, voice inflections, text, and other data sources to unlock deeper insights into how people feel and engage with the world. By prioritizing scientific rigor and ethical AI practices, Hume AI works across diverse industries—from healthcare to entertainment—to enable more authentic, empathetic, and impactful interactions between humans and technology. Hume AI was founded in 2021 and is based in New York and San Jose.

Holmusk is a health data analytics company focused on enhancing treatment for mental health and chronic diseases. It develops a real-world evidence platform that integrates specialty behavioral health data with advanced analytics to provide evidence-based insights for treatment decisions. By leveraging artificial intelligence and data science, Holmusk accelerates research and improves patient outcomes through predictive algorithms. Its proprietary modeling platform enables clients to analyze real-world data, facilitating personalized medicine and driving data-driven approaches in healthcare. The company's mission is to expand evidence-based care for individuals managing behavioral health conditions, ultimately supporting the commercialization of new treatments.

Lazzaro Medical focuses on developing innovative medical devices aimed at addressing tracheobronchomalacia (TBM), a condition affecting patients' ability to breathe effectively. The company's technology facilitates minimally invasive surgical repairs, allowing for the restoration of respiratory function in individuals suffering from tracheal and bronchial issues. By streamlining the surgical process, Lazzaro Medical's approach not only minimizes risks associated with traditional surgeries but also significantly reduces patient recovery times from several months to just days. This commitment to improving patient outcomes positions Lazzaro Medical as a key player in the medical device sector dedicated to enhancing respiratory health.

Playback Health is an AI software technology company that specializes in creating secure mobile solutions for the healthcare sector. Its platform enables healthcare providers to effectively communicate medical information and care instructions to patients, families, and other caregivers. By leveraging automation and conversational intelligence, Playback Health enhances the use of electronic medical records and patient portals, significantly improving clinician efficiency and patient engagement. The company’s SOC2 certified architecture ensures secure connections for API-enabled organizations, facilitating access to patient data throughout the care journey. Currently, Playback Health's solutions are implemented in 30 hospitals and care organizations across the United States.

Violet is a platform that helps the healthcare industry deliver more inclusive services. It enables identity-centered care for everyone.

Health Note is an AI chatbot platform that streamlines the process of collecting patient information and creating physician notes, thereby enhancing clinic workflows. Founded in 2018 and based in San Francisco, California, the platform allows patients to engage in their own care by providing pre-visit information through a simple SMS link, eliminating the need for app downloads or sign-ins. This frictionless, platform-agnostic solution integrates seamlessly with electronic medical record systems, facilitating the documentation of physician-patient interactions and improving overall healthcare efficiency.

Brightline, Inc. is a provider of pediatric behavioral health care services, established in 2019 and headquartered in Palo Alto, California. The company offers a range of services including behavior therapy, psychiatry and medication support, speech-language therapy, and occupational therapy. Brightline operates as a technology-enabled behavioral health home, utilizing innovative technology and virtual services to deliver integrated care. Its collaborative care team focuses on supporting children throughout their developmental stages and addressing the needs of their families. Brightline was previously known as Emilio Health, Inc. and rebranded in May 2020.

Ascertain is a collaborative venture between Northwell Health and Aegis Ventures, aimed at transforming healthcare through innovative company creation. This organization focuses on systematically developing, launching, and commercializing healthcare AI companies, utilizing a comprehensive platform that integrates medical, technological, data, and business resources. By addressing critical issues related to quality, equity, and cost in healthcare, Ascertain seeks to improve patient care and experience. The organization is dedicated to placing patient needs at the forefront of its business models and technology solutions, ultimately striving to enhance long-term health outcomes and advance the overall quality of care.

Transcarent is a consumer-directed health and care platform designed for employees of self-insured employers and their families. The company utilizes a blend of software, technology, and data science to provide consumers with unbiased information and trusted guidance. By connecting users to a network of high-value healthcare providers and services, Transcarent aims to empower individuals to make informed choices and achieve better health outcomes while navigating the complexities of the healthcare system. This approach fosters transparency and cost-effective decision-making, addressing a wide range of healthcare challenges faced by consumers today.

Nova Leah Ltd is a company that specializes in cybersecurity solutions for medical device manufacturers. Founded in 2015 and headquartered in Dundalk, Ireland, with an additional office in Boston, Massachusetts, it has developed SelectEvidence, a sophisticated risk analysis and treatment platform. This software assists manufacturers and healthcare providers in managing cybersecurity risks throughout the product life cycle by tracking vulnerabilities and ensuring compliance with security regulations. SelectEvidence also facilitates communication between manufacturers and hospitals through a fully traceable framework. The company provides 24/7 technical support, online training, and continuous software updates, reflecting its commitment to enhancing the security assurance of medical devices through knowledge development and collaboration.

Holmusk is a health data analytics company focused on enhancing treatment for mental health and chronic diseases. It develops a real-world evidence platform that integrates specialty behavioral health data with advanced analytics to provide evidence-based insights for treatment decisions. By leveraging artificial intelligence and data science, Holmusk accelerates research and improves patient outcomes through predictive algorithms. Its proprietary modeling platform enables clients to analyze real-world data, facilitating personalized medicine and driving data-driven approaches in healthcare. The company's mission is to expand evidence-based care for individuals managing behavioral health conditions, ultimately supporting the commercialization of new treatments.

Clarapath, Inc. is a medical robotics company that specializes in automating laboratory processes for digital pathology applications. Founded in 2011 and headquartered in New York, the company has developed Section Star, an automated device that streamlines microtomy through a tape transfer method. Clarapath provides a range of services, including routine histology, pathology consultation, whole slide imaging, quantitative image analysis, and long-term data management. Its anatomic pathology laboratory caters to both human and animal digital pathology needs, serving academic researchers and clinical laboratories. The company aims to enhance the quality and efficiency of lab medicine while reducing costs and labor-related delays. By integrating its technologies, Clarapath facilitates real-time access to tissue samples, thereby standardizing and simplifying the histology process and improving safety and throughput in laboratory settings.

Cognixion, Inc. is a technology company focused on improving communication for individuals with disabilities through innovative neurotechnology. The company develops a biosignal recognition software called Speakprose, which utilizes a brain-computer interface (BCI) to translate brainwave signals into spoken language, facilitating communication for non-verbal individuals. In addition to its software, Cognixion creates assistive devices, including a speech-generating and eye-tracking system, designed to aid those with severe speech impairments. Founded in 2014 and based in Santa Barbara, California, Cognixion aims to empower users by enabling them to express themselves and interact with their environment through thought alone. The company has also expanded its presence with an office in Toronto, Canada.

Truveta is a healthcare data platform that collaborates with physicians, life science researchers, and healthcare organizations to aggregate and analyze medical records information. By compiling data from multiple healthcare systems, Truveta de-identifies and organizes this information to provide valuable medical insights. The platform initially focused on COVID-19, aiming to expedite research efforts, enhance clinician expertise, and support families in making informed healthcare decisions. Through its innovative approach, Truveta connects treatments with outcomes and various health factors, contributing to advancements in medical research and patient care.

Conversa Health, Inc. specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare teams. The company's flagship offering, the Conversa Virtual Care and Communication Platform, streamlines patient engagement and improves health outcomes through automated, personalized messaging based on comprehensive patient profiles derived from electronic health records, biometric devices, and self-reported data. This platform enables health systems, pharmaceutical companies, and payers to shift from reactive communication to proactive engagement, facilitating better management of chronic conditions, acute discharges, and preventive care. Conversa also provides Digital Checkups, which generate tailored clinical questions and alerts based on individual patient data, and Conversa Connect, a patient profiling and health signals engine. Established in 2013 and headquartered in Portland, Oregon, with additional offices in New York, North Carolina, and California, Conversa Health serves a diverse clientele, including healthcare providers, health systems, and health technology companies.

Conversa Health, Inc. specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare teams. The company's flagship offering, the Conversa Virtual Care and Communication Platform, streamlines patient engagement and improves health outcomes through automated, personalized messaging based on comprehensive patient profiles derived from electronic health records, biometric devices, and self-reported data. This platform enables health systems, pharmaceutical companies, and payers to shift from reactive communication to proactive engagement, facilitating better management of chronic conditions, acute discharges, and preventive care. Conversa also provides Digital Checkups, which generate tailored clinical questions and alerts based on individual patient data, and Conversa Connect, a patient profiling and health signals engine. Established in 2013 and headquartered in Portland, Oregon, with additional offices in New York, North Carolina, and California, Conversa Health serves a diverse clientele, including healthcare providers, health systems, and health technology companies.

Peerbridge Health Inc. is a digital health company based in New York that specializes in remote monitoring of vital signs through its innovative wireless electrocardiogram (ECG) technology. The company has developed Peerbridge Cor, a multi-channel ECG monitor that provides physicians with real-time heart data and captures critical insights over a continuous seven-day period to aid in arrhythmia detection. In addition to Peerbridge Cor, the company offers Peerbridge CorHRV and Peerbridge Cor+, which monitor various vital signs including heart rate, respiratory rate, temperature, oxygen saturation, and heart rate variability (HRV). Peerbridge Health holds two patents related to medical-grade monitoring of vital signs, with additional patents pending, reflecting its commitment to enhancing healthcare delivery and patient outcomes through advanced technology. Founded in 2012, the company aims to improve the independence and precision of remote health monitoring for both medical and wellness applications.

Gauss Surgical, Inc. specializes in real-time blood monitoring solutions that enhance clinical decision-making in the healthcare sector. The company has developed a vision-based platform that provides accurate estimations of blood loss, facilitating timely transfusion decisions and improving patient outcomes. Its flagship product, Triton, is utilized in obstetrics to aid in the early detection of postpartum hemorrhage and offers objective metrics for assessing blood loss. Additionally, Gauss Surgical offers Triton OR, designed for operating rooms to measure blood loss from surgical sponges and suction canisters, and Triton L&D, which focuses on vaginal delivery and postpartum care. Founded in 2011, Gauss Surgical operates from its headquarters in Menlo Park, California.

Arterys Inc. is a technology company that specializes in developing a cloud-based analytics platform designed to enhance medical imaging diagnostics. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Calgary and Paris, Arterys offers a range of artificial intelligence solutions, including Cardio AI for cardiac image analysis, Lung AI for lung imaging, and Liver AI for liver assessments. Their platform provides radiologists with tools to visualize and quantify blood flow in the human body, facilitating improved patient care through advanced imaging techniques. The Arterys PHI Service allows physicians to access patient data remotely, enhancing the efficiency of medical practice. As a pioneer in internet-based medical imaging, Arterys combines web accessibility with FDA-cleared AI technology to deliver innovative clinical solutions aimed at transforming healthcare.

Vestagen Technical Textiles, founded in 2009 and based in Orlando, Florida, specializes in developing, manufacturing, and marketing innovative textile products and technologies. The company holds exclusive North American rights to patented Swiss technologies for medical textiles, allowing for versatile applications ranging from medical uniforms to athletic apparel. Vestagen's primary focus is on addressing critical needs within the healthcare industry, particularly through its proprietary VESTEX Active Barrier fabric. This advanced material is designed to protect healthcare workers and patients by minimizing the risks associated with fluid exposure and reducing the retention of harmful microorganisms on clothing.

Salaso is a developer of a software as a service platform that enables physiotherapists and other healthcare professionals to prescribe and deliver high-quality exercise videos to patients via smartphones, tablets, or personal computers. The platform includes an e-learning tool designed to engage patients with the content and promote adherence to prescribed home exercise programs. By facilitating the delivery of physiotherapy exercises, Salaso aims to support the recovery process for patients recovering from injuries, ensuring that healthcare providers can effectively manage and monitor their patients' rehabilitation efforts.

Conversa Health, Inc. specializes in patient relationship management solutions aimed at enhancing communication between patients and healthcare teams. The company's flagship offering, the Conversa Virtual Care and Communication Platform, streamlines patient engagement and improves health outcomes through automated, personalized messaging based on comprehensive patient profiles derived from electronic health records, biometric devices, and self-reported data. This platform enables health systems, pharmaceutical companies, and payers to shift from reactive communication to proactive engagement, facilitating better management of chronic conditions, acute discharges, and preventive care. Conversa also provides Digital Checkups, which generate tailored clinical questions and alerts based on individual patient data, and Conversa Connect, a patient profiling and health signals engine. Established in 2013 and headquartered in Portland, Oregon, with additional offices in New York, North Carolina, and California, Conversa Health serves a diverse clientele, including healthcare providers, health systems, and health technology companies.

Peerbridge Health Inc. is a digital health company based in New York that specializes in remote monitoring of vital signs through its innovative wireless electrocardiogram (ECG) technology. The company has developed Peerbridge Cor, a multi-channel ECG monitor that provides physicians with real-time heart data and captures critical insights over a continuous seven-day period to aid in arrhythmia detection. In addition to Peerbridge Cor, the company offers Peerbridge CorHRV and Peerbridge Cor+, which monitor various vital signs including heart rate, respiratory rate, temperature, oxygen saturation, and heart rate variability (HRV). Peerbridge Health holds two patents related to medical-grade monitoring of vital signs, with additional patents pending, reflecting its commitment to enhancing healthcare delivery and patient outcomes through advanced technology. Founded in 2012, the company aims to improve the independence and precision of remote health monitoring for both medical and wellness applications.

HealthReveal offers a cloud-based clinical analytics platform aimed at preventing the avoidable consequences of chronic diseases. Utilizing advanced analytics and biomonitoring technology, the platform continuously monitors and analyzes patient physiology and care by integrating various real-time streams of clinical, operational, and biometric data. This integration ensures that both clinicians and patients adhere to evidence-based care guidelines, facilitating the early detection and treatment of chronic conditions. The proactive approach not only aids in faster patient recovery but also contributes to reducing healthcare costs.

Clarapath, Inc. is a medical robotics company that specializes in automating laboratory processes for digital pathology applications. Founded in 2011 and headquartered in New York, the company has developed Section Star, an automated device that streamlines microtomy through a tape transfer method. Clarapath provides a range of services, including routine histology, pathology consultation, whole slide imaging, quantitative image analysis, and long-term data management. Its anatomic pathology laboratory caters to both human and animal digital pathology needs, serving academic researchers and clinical laboratories. The company aims to enhance the quality and efficiency of lab medicine while reducing costs and labor-related delays. By integrating its technologies, Clarapath facilitates real-time access to tissue samples, thereby standardizing and simplifying the histology process and improving safety and throughput in laboratory settings.

PurpleSun is an early stage healthcare technology company based out of New York City. They are focused on providing smart, light-based technology solutions to the healthcare industry for infection prevention, diagnostics and treatment. Their company’s novel light technology platform will be utilized throughout the continuum of care, within hospitals, long term care and surgical centers. The smart devices will set the stage for patient safety through the highest of quality in medical equipment disinfection. Their goal is to prevent healthcare acquired infections, which will ultimately save lives, reduce costs and enhance safety for patients and caregivers. Their clinical data proves best in class efficacy and performance of our platform, and positions PurpleSun to illuminate the healthcare arena.

Avizia is a provider of telehealth and remote conferencing solutions designed to facilitate comprehensive telehealth programs within healthcare systems. The company focuses on enhancing collaborative care by connecting medical professionals across distances through its innovative telemedicine platform. Avizia’s end-to-end solution encompasses telemedicine devices, workflow management software, and integration with electronic health records, alongside a variety of peripherals such as digital stethoscopes and examination cameras. This platform allows healthcare providers to conduct remote medical consultations and training sessions, simulating an in-person experience. By leveraging advanced video technology, Avizia enables real-time, high-definition video collaboration among patients and healthcare professionals, thereby streamlining care coordination and expanding access to medical expertise.